Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markers
about
TACC1-chTOG-Aurora A protein complex in breast cancerCXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenograftsAssociation of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancerCD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell linesALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcomeA novel triterpenoid isolated from the root bark of Ailanthus excelsa Roxb (Tree of Heaven), AECHL-1 as a potential anti-cancer agentHigh levels of the Mps1 checkpoint protein are protective of aneuploidy in breast cancer cells.Proteomics of breast cancer: principles and potential clinical applications.Contributions of advanced proteomics technologies to cancer diagnosis.Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers.Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry: prominent expression of P-cadherinIntegrating chromosomal aberrations and gene expression profiles to dissect rectal tumorigenesisGene expression profiling of solitary fibrous tumors.Aldehyde dehydrogenase 1 (ALDH1) expression is an independent prognostic factor in triple negative breast cancer (TNBC)Genome profiling of ERBB2-amplified breast cancers.Identification of proteomic signatures of mantle cell lymphoma, small lymphocytic lymphoma, and marginal zone lymphoma biopsies by surface enhanced laser desorption/ionization-time of flight mass spectrometry.The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancerGPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer.Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer.Tissue microarrays in cancer diagnosis.Overexpression of the Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in Colorectal CancerApplications of microarrays to histopathology.AECHL-1, a novel triterpenoid, targets tumor neo-vasculature and impairs the endothelial cell cytoskeleton.Involvement of mast cells in gastritis caused by Helicobacter pylori: a potential role in epithelial cell apoptosis.Measuring tissue-based biomarkers by immunochromatography coupled with reverse-phase lysate microarray.Molecular and epidemiological characteristics of inflammatory breast cancer in Algerian patients.c-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarraysAdvances in cancer tissue microarray technology: Towards improved understanding and diagnostics.Expression profiling technology: its contribution to our understanding of breast cancer.Clinical proteomics and breast cancer: strategies for diagnostic and therapeutic biomarker discovery.Using proteomic approach to identify tumor-associated antigens as markers in hepatocellular carcinomaUsing immunoproteomics to identify tumor-associated antigens (TAAs) as biomarkers in cancer immunodiagnosis.Biomarker panel diagnosis of thyroid cancer: a critical review.Prognostic significance of mucin expression profiles in breast carcinoma with signet ring cells: a clinicopathological study.Nucleic acid aptamers for targeting of shRNA-based cancer therapeutics.Glycoprotein profiles of human breast cells demonstrate a clear clustering of normal/benign versus malignant cell lines and basal versus luminal cell lines.MARCKS protein overexpression in inflammatory breast cancer.Whole-cell biochips for bio-sensing: integration of live cells and inanimate surfaces.The proteomics of pediatric brain tumors.High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses.
P2860
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
P2860
Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markers
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Distinct and complementary inf ...... study of breast tumor markers
@ast
Distinct and complementary inf ...... study of breast tumor markers
@en
type
label
Distinct and complementary inf ...... study of breast tumor markers
@ast
Distinct and complementary inf ...... study of breast tumor markers
@en
prefLabel
Distinct and complementary inf ...... study of breast tumor markers
@ast
Distinct and complementary inf ...... study of breast tumor markers
@en
P2093
P2860
P50
P1476
Distinct and complementary inf ...... study of breast tumor markers
@en
P2093
Catherine Nguyen
Christophe Ginestier
Daniel Birnbaum
Didier Bechlian
François Bertucci
François Eisinger
Jeannine Geneix
Marie-Joelle Mozziconacci
Nathalie Conte
Patrice Viens
P2860
P304
P356
10.1016/S0002-9440(10)64399-4
P407
P577
2002-10-01T00:00:00Z